"

From 2011.igem.org

Contents 1 NAD+ detection 1.1 NAD+ in general 1.2 Biosynthesis of NAD+ 1.3 Bacterial DNA ligases 1.4 Applications for molecular beacons 1.5 Further applications for the NAD+ bioassay 2 References

NAD⁺ detection

NAD⁺ in general

Nicotinamide adenine dinucleotide, abbreviated NAD⁺, is an ubiquitous and indispensable cofactor for all living organisms ([http://onlinelibrary.wiley.com/doi/10.1002/jcp.22419/full Bi et al., 2011]). The molecule has a wide range of physiological functions in cellular processes (fig. 2) and has a great impact on the cell integrity ([http://ini.sagepub.com/content/17/2/212.abstract Grahnert et al., 2011]). It is integrated into the energy metabolism and determines the redox status of the cell due to its purpose as a reduction equivalent. This is strongly linked to the control of signaling and transcriptional events. For instance, NAD⁺ has been recently described as a modulator of immune functions ([http://ini.sagepub.com/content/17/2/212.abstract Grahnert et al., 2011]) and a master regulator of transcription ([http://www.sciencedirect.com/science/article/pii/S1874939910001057 Ghosh et al., 2010]). Several enzymes are tightly regulated by the cellular balance between the oxidized and reduced form of NAD⁺ and therefore regarded as a potential target for therapeutics ([http://jpet.aspetjournals.org/content/324/3/883.abstract Sauve, 2008]). Indeed, NAD⁺ acts as a substrate for a wide range of proteins including NAD⁺-dependent protein deacetylases, poly(ADP-ribose) polymerases and several transcription factors ([http://edrv.endojournals.org/content/31/2/194.abstract Houtcooper et al., 2010]). A disorder of the cellular NAD⁺ level has usually relevance in symptoms and diseases like stroke, cardiac ischemia, epilepsy, huntington disease, wallerian degeneration, cancer, type two diabetes mellitus (T2DM), neutrophil survival, longevity, obesity as well as cardiovascular and neurodegenerative disease ([http://jpet.aspetjournals.org/content/324/3/883.abstract Sauve, 2008]; [http://edrv.endojournals.org/content/31/2/194.abstract Houtcooper et al., 2010]). The regulation of NAD⁺-dependent pathways may have a major contribution to oxidative metabolism and life span extension ([http://edrv.endojournals.org/content/31/2/194.abstract Houtcooper et al., 2010]). The biosynthetic pathways for NAD⁺ are proposed as promising novel antibiotics targets against pathogens ([http://onlinelibrary.wiley.com/doi/10.1002/jcp.22419/full Bi et al., 2011]).

Biosynthesis of NAD⁺

NAD⁺ is embedded in the cellular metabolism and has a great impact on essential cellular processes. The biosynthesis in most bacteria and plants starts with the anaerobic conversion of the amino acid aspartate to quinoline. Alternatively, in yeast, humans and some bacterial microbes the quinoline derives from tryptophan in an aerobic manner (fig 3). This is a crucial step that leads under consumption of nicotinic acid to the nicotinate ring system via formation of nicotinic acid monoculeotide (NAMN), respectively ([http://jpet.aspetjournals.org/content/324/3/883.abstract Sauve, 2008]). After conjugation of adenosine mononucleotide (AMP) the NAD synthetase forms nicotinamide adenine dinucleotide (NAD). Additionally, it has been recently reported that in humans exists an nicotinic acid-independent reaction catalysed by the enzyme nampt/PBEF, which uses directly nicotinamide as a substrate ([http://www.ncbi.nlm.nih.gov/pubmed/12555668 Rongvaux, 2002]). Diet or pharmalogical agents can thereby serve as a source for nicotinamide or nicotinic acid ([http://jpet.aspetjournals.org/content/324/3/883.abstract Sauve, 2008]). Fundamental processes as the cellular energy metabolism determine the balance between the oxidized (NAD⁺) and reduced (NADH) form of NAD.

Bacterial DNA ligases

Bacterial DNA ligases are important enzymes for DNA repair and replication. The big difference between bacterial and eukaryotic DNA ligases is their specifity for cofactors. While eukaryotic DNA ligases use ATP as a source for building a phosphodiester bond in the DNA`s phosphate backbone the bacterial ones display a NAD⁺-dependent biochemical catalysis. These enzymes are totally essential for bacterial survival and are therefore in focus for designing highly specific antiinfectives ([http://www.cell.com/structure/abstract/S0969-2126%2804%2900235-7 Gajiwala & Pinko, 2004]). All bacterial DNA ligases possess highly conserved functional domains. Generally, they can be devided into four functionally distinguishable domains, each with characteristic motifs:

• Domain 1: Ia, Ib
• Domain 2: Oligomer-binding (OB) beta-barrel
• Domain 3: Zinc-finger, helix-hairpin-helix motif (HhH)
• Domain 4: BRCT domain

All bacterial DNA ligases share three fundamental steps during reaction mechanism:

• Adenylation of DNA ligase by transferring hydrolysed AMP from NAD⁺ to the active site lysine and release of NMN
• Tranfer of the AMP from DNA ligase to the 5'-phosphate group of nicked DNA
• Formation of a phosphodiester bond by attack of the nick 3'-OH on the 5'-phosphoanhydride linkage and release of free AMP

Figure 7: During the adenylation reaction cycle of NAD+-dependent DNA ligases the linker between the two subdomains Ia (gray) and Ib (yellow) undergoes conformational change to form open and closed state. A: Open state of Ia domain exposing the adenylation site to solvent. B: Closed state of Ia domain is achieved by NAD+ binding. C: AMP-bound form providing adenylated site exposed to solvent and an open form accessible to incoming DNA. D: Deadenylated (NMN-bound) form (taken from [http://www.cell.com/structure/abstract/S0969-2126%2804%2900235-7 Gajiwala & Pinko, 2004]).

Figure 6: Model of LigA from E. coli bound to DNA. B: The different colours indicate N-terminal domain Ia (blue), nucleotidyltransferase (NTase) domain (cyan), OB-fold domain (magenta), helix-hairpin-helix (HhH) domain (beige) and a zinc (Zn)-finger domain (green). Typically, there is a BRCT domain at the C-terminus (not shown). C: Aspartic acid, arginine and glycine residues in the NTase and HhH domains are responsible for intramolecular interaction promoting protein/DNA interaction within the DNA major groove opposite the adenylated nick, called AppDNA (taken from [http://www.cell.com/molecular-cell/abstract/S1097-2765%2807%2900144-XNandakumar et al., 2007]).

Applications for molecular beacons

Molecular beacons can be applied to a wide range of biological and diagnostical studies. Whenever there is a specific nucleic acid which is supposed to be detected they can be utilized. Molecular beacons are used for the detection and distinction of retroviral DNA from different types of HIV, for instance ([http://www.sciencedirect.com/science/article/pii/S0009898105004249 Marras et al., 2006]). Even for indentification of proteins which interact with DNA or RNA they are useful. In sum, there are a lot of opportunities to apply molecular beacons ([http://www.jbsdonline.com/c3008/c4017/Molecular-Beacons-Nucleic-Acid-Hybridization-and-Emerging-Applications-p-497-504-p10542.html Antony & Subramaniam, 2001]):

• Detection of PCR amplification products
• Mutational analysis
• Genotyping and allele discrimination
• Clinical diagnosis
• Oligonucleotide degradation studies
• Analysis of DNA/RNA hybridization
• Realtime visualization of hybridization in cells
• Analysis of triplex DNA formation
• Protein/DNA interaction
• Enzymatic assays
• Biosensors

Figure 4: Hybridization of the molecular beacon and a complementary target forms the molecular beacon`s open state which leads to an increase of the fluorescence intensity. The molecular beacon can be immmobilized using specific biomolecular interaction, e.g. streptavidin/biotin or covalent cross-linking (taken from [http://www.ijcep.com/708009A.html Kim et al., 2008]).

Figure 5: Single nucleotide polymorphism of nucleic acids, including different alleles as indicated, can be detected by differently designed and labeled molecular beacons (taken from [http://www.ijcep.com/708009A.html Kim et al., 2008]).

Figure 6: Realtime in vivo imaging of specific mRNAs utilizing two MBs that target adjacent positions on the mRNA allowing FRET to take place (taken from [http://www.ijcep.com/708009A.html Kim et al., 2008]).

Further applications for the NAD⁺ bioassay

The reviewed molecular beacon based [http://pubs.acs.org/doi/abs/10.1021/ac102742k NAD⁺ bioassay] can be applied to biochemical and biomedical studies ([http://pubs.acs.org/doi/abs/10.1021/ac102742k Tang et al., 2011]). Accordingly, it can be utilized to detect NAD⁺/NADH-dependent enzymatic processes. The low limit of detection, its reliability and manageability provides a practical alternative to present colorimetric, fluorometric, chemiluminescent, electrochemical or mass spectrometric methods detecting NAD⁺ or NADH. In context of clinical applications and therapeutics the [http://pubs.acs.org/doi/abs/10.1021/ac102742k NAD⁺ bioassay] can be useful to monitor cellular NAD⁺ levels during treatments of tissues or cell cultures for identification of drug targets, for instance. It may also be applied in the field of diagnostics. Finally, the principle of the proposed [http://pubs.acs.org/doi/abs/10.1021/ac102742k NAD⁺ bioassay] can be used for cell-free optical biosensors by taking molecular beacons either immobilized on the sensor surface or being present in the reaction medium ([http://pubs.acs.org/doi/abs/10.1021/ac102742k Tang et al., 2011]).

References

Antony T, Subramaniam V (2001) Molecular Beacons: Nucleic Acid Hybridization and Emerging Applications, [http://www.jbsdonline.com/c3008/c4017/Molecular-Beacons-Nucleic-Acid-Hybridization-and-Emerging-Applications-p-497-504-p10542.html Journal of Biomolecular Structure & Dynamics 19(3):497-504].

Bi J, Wang H, Xiel J (2011) Comparative genomics of NAD(P) biosynthesis and novel antibiotic drug targets, [http://onlinelibrary.wiley.com/doi/10.1002/jcp.22419/full Journal of Cellular Physiology 226(2):331-340].

Gajiwala KS, Pinko C (2004) Structural Rearrangement Accompanying NAD⁺ Synthesis within a Bacterial DNA Ligase Crystal, [http://www.cell.com/structure/abstract/S0969-2126%2804%2900235-7 Structure 12(8):1449-1459].

Ghosh S, George S, Roy U, Ramachandran D, Kolthur-Seetharam U (2010) NAD: A master regulator of transcription, [http://www.sciencedirect.com/science/article/pii/S1874939910001057 Biochimica et Biophysica Acta 1799(10-12):681-693].

Grahnert A, Grahnert A, Klein C, Schilling E, Wehrhahn J, Hauschildt S (2011) NAD⁺: A modulator of immune functions, [http://ini.sagepub.com/content/17/2/212.abstract Innate Immunity 17(2):212-233].

Houtkooper RH, Cantó C, Wanders RJ, Auwerx J (2010) The Secret Life of NAD⁺: An Old Metabolite Controlling New Metabolic Signaling Pathways, [http://edrv.endojournals.org/content/31/2/194.abstract Endocrine Reviews 31(2):194-223].

Kim Y, Sohn D, Tan W (2008) Molecular Beacons in Biomedical Detection and Clinical Diagnosis, [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480550/?tool=pmcentrez&rendertype=abstract International Journal of Clinical and Experimental Pathology 1:105-116].

Marras SA, Tyagi S, Kramer FR (2006) Real-time assays with molecular beacons and other fluorescent nucleic acid hybridization probes, [http://www.sciencedirect.com/science/article/pii/S0009898105004249 Clinica chimica acta 363(1-2):48-60].

Nandakumar J, Nair PA, Shuman S (2007) Last Stop on the Road to Repair: Structure of E. coli DNA Ligase Bound to Nicked DNA-Adenylate, [http://www.cell.com/molecular-cell/abstract/S1097-2765%2807%2900144-X Molecular Cell 26(2):257-271].

Rongvaux A, Shea RJ, Mulks MH, Gigot D, Urbain J, Leo O, Andris F (2002) Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis, [http://www.ncbi.nlm.nih.gov/pubmed/12555668 European Journal of Immunology 32(11):3225-3234].

Sauve AA (2008) NAD⁺ and Vitamin B3: From Metabolism to Therapies, [http://jpet.aspetjournals.org/content/324/3/883.abstract The Journal of Pharmacology and Experimental Therapeutics 324(3):883-893].